Evidence map›Paper›PMID 41488563›Full record

ArticleJAAD international2026

Utilization and predictors of use of immunomodulators for atopic dermatitis: A cohort study.

Priyanka Anand, Arash Mostaghimi, Robert Glynn, Yinzhu Jin, Joseph F Merola, Jonathan I Silverberg, David M Rosmarin, Robert Sidbury, Joan Landon, Maria C Schneeweiss

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Priyanka AnandDermato-Pharmacoepidemiology Work Group, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Arash MostaghimiHarvard Medical School, Boston, Massachusetts.
Robert GlynnDermato-Pharmacoepidemiology Work Group, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Yinzhu JinDermato-Pharmacoepidemiology Work Group, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Joseph F MerolaDepartment of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center, Dallas, Texas.
Jonathan I SilverbergDepartment of Dermatology, George Washington University School of Medicine and Health Sciences, Washington DC.
David M RosmarinDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana.
Robert SidburyDivision of Dermatology, Department of Pediatrics, Seattle Children's Hospital, Seattle, Washingtom.
Joan LandonDermato-Pharmacoepidemiology Work Group, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Maria C SchneeweissDermato-Pharmacoepidemiology Work Group, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Funding

New approaches to safety monitoring of novel systemic treatments for atopic dermatitis in clinical practice and underrepresented populationsR01AR080194 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Sebastian G. Schneeweiss · 2022 to 2026
$3.3M
NIAMS NIH HHS R01 AR080194
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atopic dermatitiscytokine inhibitorsepidemiologyimmunomodulatorsJAK inhibitorsutilization

Identifiers

PMID41488563
PMCPMC12756003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.